Efficacy and Safety of Insulin Rinsulin® NPH Compared to Humulin® NPH in Type 2 Diabetes Mellitus Patients

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 201 participants.

Also called NCT04012775

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 201 participants (enrolled count) (from the registry)
Sponsor
  • Geropharm Registry lists this organization as the lead sponsor
Registry
  • NCT NCT04012775
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Russia (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT04012775. Randomized; no masking; primary purpose treatment. Start 2017-04-20 (actual); primary completion 2018-09-24 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Efficacy and Safety of Insulin Rinsulin® NPH Compared to Humulin® NPH in Type 2 Diabetes Mellitus Patients
Condition
Diabetes Mellitus, Type 2
Intervention (Biological)
Insulin Humulin® NPH
Intervention (Biological)
Insulin Rinsulin® NPH
Lead sponsor
Geropharm (class: industry)

Record details

Record id
cardio:ct-nct04012775
Content hash
c072c282136eddd8b88674fe7347b847966cbbbc77bdf2fc0bafe6c4a89421aa